EtDO-P4 is a nanomolar inhibitor of glycosphingolipid (GSL) synthesis. EtDO-P4 suppresses activation of the EGFR-induced ERK pathway and various receptor tyrosine kinases (RTKs). EtDO-P4 can be used for various types of cancer, including Burkitts lymphoma[1].
Molecular Weight:
516.76
Purity:
98.75
CAS Number:
[245329-78-6]
Formula:
C31H52N2O4
Target:
ERK
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted